期刊
ONCOIMMUNOLOGY
卷 11, 期 1, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/2162402X.2022.2096572
关键词
Oncolytic virus; adenovirus; interleukin 7; immunotherapy
资金
- Doctoral programme in clinical research (University of Helsinki)
- Jane and Aatos Erkko Foundation
- Finnish Cancer Organizations
- Novo Nordisk Foundation
- Paivikki and Sakari Sohlberg Foundation
- TILT Biotherapeutics Ltd
- Marie Sklodowska-Curie
- Suomen Kulttuurirahasto
- Doctoral programme in clinical research, University of Helsinki, Finland
- TILT Biotherapeutics Ltd.
- HUCH Research Funds (VTR)
The study demonstrates that arming an oncolytic adenovirus with Interleukin 7 can effectively decrease tumor growth and increase immune cell infiltration in the tumor microenvironment. This approach offers a potential solution to overcome the limitations of conventional Interleukin 7 therapy and may have clinical implications.
Cytokines have proven to be effective for cancer therapy, however whilst low-dose monotherapy with cytokines provides limited therapeutic benefit, high-dose treatment can lead to a number of adverse events. Interleukin 7 has shown promising results in clinical trials, but anti-cancer effect was limited, in part due to a low concentration of the cytokine within the tumor. We hypothesized that arming an oncolytic adenovirus with Interleukin 7, enabling high expression localized to the tumor microenvironment, would overcome systemic delivery issues and improve therapeutic efficacy. We evaluated the effects of Ad5/3-E2F-d24-hIL7 (TILT-517) on tumor growth, immune cell activation and cytokine profiles in the tumor microenvironment using three clinically relevant animal models and ex vivo tumor cultures. Our data showed that local treatment of tumor bearing animals with Ad5/3- E2F-d24-hIL7 significantly decreased cancer growth and increased frequency of tumor-infiltrating cells. Ad5/3-E2F-d24-hIL7 promoted notable upregulation of pro-inflammatory cytokines, and concomitant activation and migration of CD4+ and CD8 + T cells. Interleukin 7 expression within the tumor was positively correlated with increased number of cytotoxic CD4+ cells and IFNg-producing CD4+ and CD8+ cells. These findings offer an approach to overcome the current limitations of conventional IL7 therapy and could therefore be translated to the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据